Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01633060
Title A Phase III Study of BKM120 With Fulvestrant in Patients With HR+, HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Acronym BELLE-3
Recruitment Terminated
Gender female
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
University of South Alabama / Mitchell Cancer Institute Univ South AL Mobile Alabama 36688 United States Details
Ironwood Cancer and Research Centers SC Chandler Arizona 85224 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Compassionate Cancer Care Medical Group CCCMG Fountain Valley California 92708 United States Details
Los Angeles Hematology/Oncology Medical Group Onc Dept. Los Angeles California 90017 United States Details
Cedars Sinai Medical Center SC-5 Los Angeles California 90048 United States Details
University of California at Los Angeles UCLA SC Los Angeles California 90095 United States Details
Pacific Cancer Care Monterey California 93940 United States Details
Rocky Mountain Cancer Centers SC Denver Colorado 80218 United States Details
University Cancer & Blood Center, LLC Athens Georgia 30607 United States Details
Emory University School of Medicine/Winship Cancer Institute Emory Atlanta Georgia 30322 United States Details
Moanalua Medical Center. Attn: Oncology Dept Honolulu Hawaii 96817 United States Details
Edward Hospital Edward Hospital Naperville Illinois 60540 United States Details
Crescent City Research Consortium, LLC SC Metairie Louisiana 70006 United States Details
Lsu Health Sciences Center/ Lsu School of Medicine Lsu New Orleans Louisiana 70115 United States Details
John Ochsner Heart and Vascular Institute Clinical Trials Ochsner 2 New Orleans Louisiana 70121 United States Details
LSU Health Sciences Center Feist-Weiller Cancer Center New Orleans Louisiana 70122-2822 United States Details
University of Maryland Medical Center Univ Maryland Baltimore Maryland 21201 United States Details
Mercy Medical Research Institute SC Manchester Missouri 63021 United States Details
Morristown Memorial Hospital Morristown Mem Morristown New Jersey 07962 United States Details
CINJ at Cooper University Hospital Dept of Onc Voorhees New Jersey 08043 United States Details
Montefiore Medical Center Montefiore Bronx New York 10467 United States Details
Clinical Research Alliance BKM120F2303 Lake Success New York 11042 United States Details
Clinical Research Alliance Lake Success New York 11042 United States Details
Northwest Cancer Specialists Compass Oncology -BKM Portland Oregon 97210 United States Details
Oregon Health and Science University SC-5 Portland Oregon 97239 United States Details
University of Pittsburgh Cancer Institute Dept of Magee Women's Hospital Pittsburgh Pennsylvania 15232 United States Details
The West Clinic Dept. of the West Clinic Memphis Tennessee 38120 United States Details
Texas Oncology PA Dallas Presbyterian Hospital SC Dallas Texas 75231 United States Details
Texas Oncology Texas Oncology - Sammons Dallas Texas 75246 United States Details
Texas Oncology P A SC-Austin Dallas Texas 75251 United States Details
Texas Oncology P A Texas Oncology - Fort Worth (3 Dallas Texas 75251 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Texas Tech University Health Science Center Dept of Texas Tech El Paso Texas 79905 United States Details
The Methodist Hospital Cancer Center Houston Texas 77030 United States Details
US Oncology, P.A. Tyler Texas 75702 United States Details
Northwest Medical Specialties Tacoma Washington 98405 United States Details
Novartis Investigative Site Caba Buenos Aires C1050AAK Argentina Details
Novartis Investigative Site Rosario Santa Fe S2000KZE Argentina Details
Novartis Investigative Site San Miguel De Tucuman Tucuman T4000IAK Argentina Details
Novartis Investigative Site Rio Negro Viedma 8500 Argentina Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Linz 4010 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Plovdiv 4000 Bulgaria Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Sofia 1527 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Vratsa 3000 Bulgaria Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Montreal Quebec H3A 1A1 Canada Details
Novartis Investigative Site Bogota Colombia Details
Novartis Investigative Site Monteria Colombia Details
Novartis Investigative Site Tampere FIN-33521 Finland Details
Novartis Investigative Site Nice Cedex 2 Alpes Maritimes 06189 France Details
Novartis Investigative Site Limoges cedex Haute Vienne 87000 France Details
Novartis Investigative Site Saint-Cloud Hauts De Seine 92210 France Details
Novartis Investigative Site Reims Cedex Marne 51056 France Details
Novartis Investigative Site Angers Cedex 02 49055 France Details
Novartis Investigative Site Clermont-Ferrand 63011 France Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Rouen Cedex 1 76038 France Details
Novartis Investigative Site Saint-Brieuc Cédex 22015 France Details
Novartis Investigative Site Saint-Herblain Cédex 44805 France Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Berlin 12203 Germany Details
Novartis Investigative Site Bonn 53111 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Frankfurt 60389 Germany Details
Novartis Investigative Site Fulda 36043 Germany Details
Novartis Investigative Site Karlsruhe 76135 Germany Details
Novartis Investigative Site Kiel 24103 Germany Details
Novartis Investigative Site Leer 26789 Germany Details
Novartis Investigative Site Magdeburg 39120 Germany Details
Novartis Investigative Site Mannheim 68165 Germany Details
Novartis Investigative Site Muenchen 80637 Germany Details
Novartis Investigative Site Muenchen 81377 Germany Details
Novartis Investigative Site Mühlhausen 99974 Germany Details
Novartis Investigative Site Ravensburg 88214 Germany Details
Novartis Investigative Site Soest 59494 Germany Details
Novartis Investigative Site Tuebingen 72076 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Velbert 42551 Germany Details
Novartis Investigative Site Marousi Athens 15123 Greece Details
Novartis Investigative Site Athens GR 151 23 Greece Details
Novartis Investigative Site Larissa GR 411 10 Greece Details
Novartis Investigative Site Patra - RIO GR 265 04 Greece Details
Novartis Investigative Site Thesaloniki Thessaloniki 54622 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Athens GR-115 22 Greece Details
Novartis Investigative Site Heraklion Crete 711 10 Greece Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Budapest H-1122 Hungary Details
Novartis Investigative Site Szeged H-6720 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site L'Aquila AQ 67100 Italy Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Benevento BN 82100 Italy Details
Novartis Investigative Site Brindisi BR 72100 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Monserrato CA 09042 Italy Details
Novartis Investigative Site Cremona CR 26100 Italy Details
Novartis Investigative Site Catania CT 95100 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Cona FE 44100 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Sora FR 03039 Italy Details
Novartis Investigative Site Lecco LC 23900 Italy Details
Novartis Investigative Site Lecce LE 73100 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Macerata MC 62100 Italy Details
Novartis Investigative Site Messina ME 98158 Italy Details
Novartis Investigative Site Milano MI 20121 Italy Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Pisa PI 56126 Italy Details
Novartis Investigative Site Pordenone PN 33170 Italy Details
Novartis Investigative Site Prato PO 59100 Italy Details
Novartis Investigative Site Parma PR 43100 Italy Details
Novartis Investigative Site Pavia PV 27100 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Salerno SA 84131 Italy Details
Novartis Investigative Site Sassari SS 07100 Italy Details
Novartis Investigative Site Candiolo TO 10060 Italy Details
Novartis Investigative Site Ivrea TO 10015 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Mirano VE 30035 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Frattamaggiore 80020 Italy Details
Novartis Investigative Site Gyeonggi-do Korea 10408 Korea, Republic of Details
Novartis Investigative Site Seoul Korea 03080 Korea, Republic of Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Maastricht AZ 5800 Netherlands Details
Novartis Investigative Site Breda 4819 EV Netherlands Details
Novartis Investigative Site Delft NL 2625 AD Netherlands Details
Novartis Investigative Site Deventer 7416 SE Netherlands Details
Novartis Investigative Site Hoofddorp 2134 TM Netherlands Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Sittard-Geleen 6162 BG Netherlands Details
Novartis Investigative Site Zwolle 8025 AB Netherlands Details
Novartis Investigative Site Bergen 5021 Norway Details
Novartis Investigative Site Oslo NO 0450 Norway Details
Novartis Investigative Site Olsztyn 10226 Poland Details
Novartis Investigative Site Elche Alicante 03203 Spain Details
Novartis Investigative Site Jaen Andalucia 23007 Spain Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Sevilla Andalucia 41009 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Barcelona Catalunya 08003 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Castellon Comunidad Valenciana 12002 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46009 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46014 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Palma De Mallorca Islas Baleares 07120 Spain Details
Novartis Investigative Site La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28007 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Santa Cruz de Tenerife 38009 Spain Details
Novartis Investigative Site Kalmar SE-391 85 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Uppsala 751 85 Sweden Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Blackburn Lancashire BB2 3HH United Kingdom Details
Novartis Investigative Site Ipswich Suffolk IP4 5PD United Kingdom Details
Novartis Investigative Site Edinburgh EH4 2XU United Kingdom Details
Novartis Investigative Site London SM2 5PT United Kingdom Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field